FDA GFI, Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial, 11/22 Anastasija Eschricht2023-02-08T10:21:45+00:00February 8th, 2023| About the Author: Anastasija Eschricht